This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The General Hospital Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Derin Sevenler: Innovator in Cryopreservation Technology
Introduction
Derin Sevenler is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of cryopreservation through his innovative work on hydrogel beads. His research focuses on enhancing the viability of lymphocytes after cryopreservation, which is crucial for various medical applications.
Latest Patents
Derin Sevenler holds a patent for "Hydrogel beads for controlled uptake and release of cryoprotective agents." This invention provides hydrogel beads that have tunable rates of loading and unloading of cryoprotective agents. These beads can be dispersed throughout a cell suspension, enabling a gradual and distributed manner of loading and unloading cryoprotective agents from cells. This method protects the cells from osmotic damage, significantly improving lymphocyte viability after cryopreservation compared to conventional media exchange methods. He has 1 patent to his name.
Career Highlights
Derin Sevenler is associated with The General Hospital Corporation, where he continues to advance his research in cryopreservation technologies. His work has the potential to impact various fields, including regenerative medicine and cell therapy.
Collaborations
Throughout his career, Derin has collaborated with notable professionals in his field, including Mehmet Toner and Rebecca Sandlin. These collaborations have further enriched his research and contributed to the development of innovative solutions in cryopreservation.
Conclusion
Derin Sevenler is a pioneering inventor whose work on hydrogel beads has the potential to revolutionize cryopreservation techniques. His contributions are vital for improving cell viability and advancing medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
